 LiveScience.com |
Omalizumab improves asthma control in inner-city children
Clinical Advisor Adding omalizumab to guidelines-directed asthma therapy reduces seasonal exacerbations and the need for controller medication among inner-city children, regardless of asthma severity, results from the Inner City Anti-IgE Therapy for Asthma (ICATA) … Omalizumab 'cuts seasonal asthma attacks in youth' Drug may relieve kids' asthma in the fall Asthma Drug Cuts Seasonal Flares for Inner-City Kids |
View full post on asthma – Google News